Hip Protectors: Clinical and Cost Effectiveness (Last Updated: Oct 21, 2016)
Project Line:
Reference List
Current Filters
Evidence on Topics Related to Aging and Health Remove
Hip Protectors for Community-Dwelling Older Adults (Last Updated: Sep 2, 2021)
Project Line:
Health Technology Review
Screening for Cognitive Impairment in Asymptomatic Community-Dwelling Older Adults: Clinical Utility and Guidelines (Last Updated: Oct 13, 2020)
Project Line:
Reference List
Pill Crushing Devices and Pill Swallowing Gels for Use in Health Care Settings (Last Updated: Jun 10, 2021)
Project Line:
Reference List
Hypodermoclysis for Frail Patients and Patients in Long Term Care: A Review of Clinical Effectiveness, Cost Effectiveness, and Guidelines (Last Updated: Aug 31, 2020)
Project Line:
Health Technology Review
Patient Navigation Programs for People with Dementia: Clinical Utility, Cost-Effectiveness, and Guidelines (Last Updated: Dec 7, 2020)
Project Line:
Reference List
Interventions That Produce Residual Inhibition for the Treatment of Tinnitus: Clinical Effectiveness and Guidelines (Last Updated: May 30, 2019)
Project Line:
Reference List
Overnight Bags for Adults With Long-Term Indwelling Urinary Catheters: Clinical Effectiveness, Cost-Effectiveness, and Guidelines (Last Updated: Aug 7, 2019)
Project Line:
Reference List
brolucizumab (Beovu) (Last Updated: Jul 3, 2020)
Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name
Manufacturer
Submission Type
Indications
Brand Name:
Beovu
Manufacturer:
Novartis Pharmaceuticals Canada Inc.
Submission Type:
Initial
Indications:
Macular degeneration, age-related
Electroconvulsive Therapy for the Treatment of the Behavioural and Psychological Symptoms of Dementia: A Review of Clinical Effectiveness and Guidelines (Last Updated: May 22, 2019)
Project Line:
Health Technology Review